Evidence map›Paper›PMID 34682926›Full record

ArticleHealthcare (Basel, Switzerland)2021

Readability Assessment of HPV Vaccination and Cervical Cancer Information: A Systematic Scoping Review.

Tsuyoshi Okuhara, Hiroko Okada, Eiko Goto, Takahiro Kiuchi

Abstract readScoping Review
In one paragraph

Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tsuyoshi OkuharaDepartment of Health Communication, School of Public Health, The University of Tokyo, Tokyo 113-8655, Japan.ORCID 0000-0002-6251-3587
Hiroko OkadaDepartment of Health Communication, School of Public Health, The University of Tokyo, Tokyo 113-8655, Japan.
Eiko GotoDepartment of Health Communication, School of Public Health, The University of Tokyo, Tokyo 113-8655, Japan.
Takahiro KiuchiDepartment of Health Communication, School of Public Health, The University of Tokyo, Tokyo 113-8655, Japan.

Funding

The Japan Society for the Promotion of Science KAKENHI 19K10615
6 · The paper itself

Abstract

It is important to provide information on HPV vaccination and on early detection and early treatment for cervical cancer. Readability is a key aspect in the success of cancer communication using written health information. We reviewed studies assessing the readability of information on HPV vaccination and cervical cancer. We conducted a systematic literature search in June 2021 using four online databases (Medline, CINAHL, PsycArticles, and PsycINFO). Studies that assessed the readability level of online and offline information regarding HPV vaccination and cervical cancer were included in the review. Twelve articles were deemed fit for study inclusion. Our results showed that most of the materials assessed were difficult to read and higher than eighth-grade reading level. Few of the materials assessed were at the recommended grade 5-6 level or below. Readability assessments of HPV vaccination and cervical cancer information are scarce. Additional studies on the readability of information regarding HPV vaccination and cervical cancer are recommended. Health professionals should develop health information on HPV vaccination and cervical cancer that is easy to read.

Indexed as

cervical cancerhealth communicationhealth literacyHPV vaccinationpatient educationreadabilitywritten health information

Identifiers

PMID34682926
PMCPMC8535382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.